Table II.
[(−)-Ipsdienol] (μM) | Inhibitor | [Inhibitor] (μM) | Specific activity (nmol·min−1·mg−1) |
KI | |
---|---|---|---|---|---|
without inhibitor | with inhibitor | ||||
16 a | Ipsdienone | 16 | 0.308 | 0.246 | 29 μM |
16 | Ipsdienone | 16 | 0.650 | 0.573 | 15 μM |
4 | (−)-Menthone | 16–35 | 0.330 | 0.228 | 30 μMb |
16 | 1-Propanol | 33,300 | 0.308 | 0.126 | 33.6 mM |
16 | 2-Propanol | 33,300 | 0.308 | 0.441 | 9.9 mM |
10 | β-Estradiol | 39 | 0.981 | 0.783 | 25 μMc |
16 | 1,3-Butanediol | 16 | 0.213 | 0.245 | — |
16 | 8β,9α Ryanoid | 16 | 0.194 | 0.195 | — |
16 | 10-Epi ryanoid | 16 | 0.194 | 0.197 | — |
16 | Nerol | 16 | 0.182 | 0.197 | — |
16 | Geraniol | 16 | 0.182 | 0.207 | — |
16 | Citral | 16 | 0.182 | 0.203 | — |
16 | (+)-Ipsdienol | 16 | 0.396 | 0.389 | — |
aSample contained 25 mM NADP instead of 2.5 mM NADP
bAverage value obtained from experiments with variable (−)-menthone concentrations
cExperiment done once.